BloodSTOP iX Trauma Matrix (TM-iX-20)
K-Number: K253017 · 2026-04-30
ApplicantLifescience Plus, Inc.
Decision Date2026-04-30
Product CodeQSY
DecisionSubstantially Equivalent
Device Summary
BloodSTOP iX Trauma Matrix (TM-iX-20) is a medical device manufactured by Lifescience Plus, Inc.. It received FDA 510(k) clearance on 2026-04-30 under approval number K253017. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the BloodSTOP iX Trauma Matrix (TM-iX-20)?
BloodSTOP iX Trauma Matrix (TM-iX-20) is a medical device that received FDA 510(k) clearance on 2026-04-30. It is manufactured by Lifescience Plus, Inc.. The 510(k) number is K253017.
When was BloodSTOP iX Trauma Matrix (TM-iX-20) approved by the FDA?
BloodSTOP iX Trauma Matrix (TM-iX-20) received FDA 510(k) clearance on 2026-04-30, under approval number K253017.
What company makes BloodSTOP iX Trauma Matrix (TM-iX-20)?
BloodSTOP iX Trauma Matrix (TM-iX-20) is manufactured by Lifescience Plus, Inc..
What is the FDA product code for BloodSTOP iX Trauma Matrix (TM-iX-20)?
The FDA product code for BloodSTOP iX Trauma Matrix (TM-iX-20) is QSY.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.